We report a case of intrathoracic malignant peripheral nerve sheath tumor in a -year old woman revealed after a few-month history of progressive dyspnea, appetite and body mass loss. Th e chest magnetic resonance (MR) examination revealed the presence of a large tumor occupying the mediastinum and a major portion of the right hemithorax. Th e diagnostic tumor sample was obtained by parasternal biopsy in local anesthesia. Th e surgical resection of the tumor could not be performed due to its excessive size, intrathoracic involvement and bad respiratory reserves of a patient. Th e chemotherapy and irradiation were performed as palliative measures. Th e lethal outcome appeared  months after the diagnosis was established. 
Case report
The patient was a -year old woman, a non-smoker, who was developing the disease gradually, over a couple of months, exhibiting the symptoms of difficult breathing, dyspnea on exertion, appetite and weight loss. For the last  years she was suff ering from chronic obstructive pulmonary disease (COPD). The chest X-ray revealed a large homogeneous opacity, almost entirely occupying the right hemithorax with a consequent displacement of the mediastinal structures to the left ( Figure  ).
The chest magnetic resonance (MR) examination confirmed the presence of an intrathoracic tumor, solid in structure, involving the mediastinum, measuring xx cm. The tumor occupied the mediastinal space involving almost completely the right hemithorax, from the prevertebral fascia to the anterior chest wall, reaching the upper thoracic aperture. The tumor also encircled and deformed the lumen of the trachea and large blood vessels. The bone structures remained intact ( Figure  ). (Figure d) . On the basis of the histological evaluation, the diagnosis of malignant infiltrative pulmonary peripheral nerve sheath tumor was finally established.
As the surgical resection of the tumor could not be performed due to its excessive size, intrathoracic involvement and bad respiratory reserves of a patient, single course chemotherapy with Ifosphamide and Uromitexane was administered, accompanied by a split-course palliative irradiation therapy in dose of  Gy, because of tumor-induced compression of the mediastinal structures. A lethal outcome occurred  months after the diagnosis had been established.
Discussion
Neurogenic tumors make about - of all mediastinal tumors. Th ese tumors may develop from peripheral nerves, nerve sheaths or from sympathetic ganglions [] .Th ey are most commonly localized in the posterior mediastinum [] , originating in most cases from the intercostals nerves [] . Formerly, neurogenic malignant tumors were classified under different names (malignant schwannoma, neurogenic sarcoma or neurofi brosarcoma) and today they are generally designated by the term malignant peripheral nerve sheath tumors (MPNST) [] . Both sexes are almost equally affected with these tumors, although in some studies the slight predominance of the aff ected females was noted [] . Th ey are commonly revealed in the - years age group [] . The subjects suffering from neurofibromatosis I (NF) have a greater risk of MPNST. These tumor occur in about - of NF patient compared with an incidence of . in the general population [] . They most frequently aff ect the extremities, but may also affect other areas, predominantly head, neck, pelvis and retroperitoneum [,] , but it rarely develops in the thoracic cavity [] . MPNST usually cause no symptoms [] . Due to compression of the intercostal nerve or large airways, some patients may develop pain or dyspnea, or some other respiratory symptoms, like cough [] .Our patient had a severe dyspnea due to tumor-induced compression on the trachea and large airways. When MPNST involve deep tissue nerves, it can hardly be directly observed, so the early diagnosis is diffi cult [] . MPNST is therefore usually detected in its advanced stage, when it has already reached a considerable size [] . Th e method of choice for the treatment of MPNST is an extensive and total surgical resection [-,] . In patients with unresectable tumor chemotherapy and radiotherapy are modality of treatment [] . MPNST unfortunately belong to the group of chemo and irradiation resistant tumor [] . A curative chemotherapy regimen for MPNST has not been recommended yet [] , so chemotherapy is sometimes applied for palliation purposes [] .The efficacy of the new drugs such as anti-angiogenic agents and epidermal growth factor receptor antagonists is still being evaluated in the ongoing clinical trials [] .With the latest advances in molecular genetics, the target therapy for this tumor type is expected to be discovered [] .
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